Delineating the complicated relationships among EGFR, MRP1 and α5β1 integrins in T-DM1-resistant breast cancer cells may lead to a better understanding of biological consequences resulting from the dysregulation of these critical molecules and development of novel combination therapies to prevent or overcome T-DM1-resistant disease. Here, ABCC1 is linked to breast carcinoma.